Wang, X., Bera, K., Barrera, C., Zhou, Y., Lu, C., Vaidya, P., Yang, M., Schmid, R., Berezowska, S., Choi, H., Velcheti, V., & Madabhushi, A.(2021).A prognostic and predictive computational pathology image signature for added benefit of adjuvant chemotherapy in early stage non-small-cell lung cancer.EBioMedicine.
WAng, X., Bera, K., Barrera, C., Zhou, Y., Lu, C., Vaidya, P., Fu, P., Yang, M., Schmid, R., Berezowska, S., Choi, H., Velcheti, V., & Madabhushi, A.(2021).A prognostic and predictive computational pathology image signature for added benefit of adjuvant chemotherapy in early stage non-small-cell lung cancer.EBIOMEDICINE,69
Khorrami, M., Bera, K., Leo, P., Vaidya, P., Patil, P., Thawani, R., Velu, P., Rajiah, P., Alilou, M., Choi, H., Feldman, M., Gilkeson, R., Linden, P., Fu, P., Pass, H., Velcheti, V., & Madabhushi, A.(2020).Stable and discriminating radiomic predictor of recurrence in early stage non-small cell lung cancer: Multi-site study.Lung Cancer,142, 90-97.
Vaidya, P., Bera, K., Gupta, A., WAng, X., Corredor-Prada, G., Fu, P., Beig, N., Prasanna, P., Patil, P., Velu, P., Rajiah, P., Gilkeson, R., Feldman, M., Choi, H., Velcheti, V., & Madabhushi, A.(2020).CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in stage I, II resectable non-small cell lung cancer: a retrospective multicohort study for outcome prediction.The Lancet Digital Health,2(3),e116-e128.
Vaidya, P., Bera, K., Patil, P., Gupta, A., Jain, P., Alilou, M., Khorrami, M., Velcheti, V., & Madabhushi, A.(2020).Novel, non-invasive imaging approach to identify patients with advanced non-small cell lung cancer at risk of hyperprogressive disease with immune checkpoint blockade.Journal for immunotherapy of cancer,8(2).
Khorrami, M., Bera, K., Leo, P., Vaidya, P., Patil, P., Thawani, R., Velu, P., Rajiah, P., Alilou, M., Choi, H., & Others, H.(2020).Stable and discriminating radiomic predictor of recurrence in early stage non-small cell lung cancer: Multi-site study.Lung Cancer,142, 90--97.
Patil, P., Bera, K., Vaidya, P., Prasanna, P., Khunger, M., Khunger, A., Velcheti, V., & Madabhushi, A.(2018).Correlation of radiomic features with PD-L1 expression in early stage non-small cell lung cancer (ES-NSCLC) to predict recurrence and overall survival (OS)..Journal of Clinical Oncology,36(15_suppl),e24247-e24247.
